A waiver which allows EU generic and biosimilar manufacturers to export and stockpile SPC-protected medicines will apply where the SPCs come into force after July 1st, 2019 A transitional… read more…
In this article for Intellectual Property Magazine, Partner Martin MacLean and Trainee Patent Attorney Lionel Newton explain how innovators are responding to the increased demand for clean tech… read more…
Mathys & Squire Associate Alexander Robinson and Partner Stephen Garner explore some of the regulatory issues in the life sciences and pharmaceutical sectors that are likely to be affected by… read more…
Mathys & Squire is thrilled to be once again a recommended firm in the latest edition of IAM Patent 1000 Four of our partners were this year singled out as recommended individuals in the firm… read more…
Interest in cell-cultured meat has been steadily gaining momentum since the first laboratory-grown burger was unveiled in 2013 by scientists from Maastricht University in the Netherlands In… read more…
Will you be attending the 2019 AIPPI World Congress If so, Mathys & Squire would like to invite you to join us for drinks with a view at our London office in The Shard to celebrate! AIPPI is the… read more…
Mathys & Squire will once again be sponsoring and exhibiting at the flagship event for London Tech Week, TechXLR8, which brings together seven of the biggest technology conferences with over… read more…
Mathys & Squire LLP has promoted Hazel Ford and Posy Drywood to the partnership The firm now has 27 partners and 10 offices across the UK and Europe Hazel Ford has nearly 20 years’ experience… read more…
For small companies in the medtech space, the most usual exit is to be acquired by a larger corporation Having seen this process from both sides, through advising a vast number of startups and… read more…